Training activity information
Details
Interpret and report pharmacogenetic testing in oncology patients, to include:
- DPYD
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee​.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Screening strategy
- Methodologies and limitations
- Clinical and scientific basis, including adapting language to describe the interpretation appropriately
- Application of results to patient treatment
- Impact of ethnicity
- Integrated reporting
- Local format for reporting
- Best practice guidance
- Local and national guidance
- Implications and recommendations
- Sensitivity and limitations
- Quality control, including IQC, and EQA
- Nomenclature, correct scientific and clinical terminology
- Local SOPs
- Confidentiality and information governance
- Communication of complex scientific information to clinicians and patients
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 6 |
Outcome
Analyse, interpret and report pharmacogenetic testing in oncology patients. |